Experts warn widespread HCV screening harms may outweigh benefits

January 14, 2015 6:57 PM

19 0

Many organizations have endorsed expanding widespread screening of hepatitis C virus infection, but experts writing in The BMJ warn that physicians should resist screening until more evidence on the risk–benefit ratio and long-term clinical improvements with antiviral therapy becomes available.

“Expanding screening for hepatitis C to the entire population of persons born between 1945 and 1965 is based on two unproven assumptions: that the benefits of treatment of screen-detected persons will outweigh the harms, and that the 3- or 6-month surrogate outcomes (viral suppression) observed in t...

Read more

To category page